| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PETR4
|
45.02 | 580.3B | 5.31 | 1.30 | 3.64 | 12.7% | 10.8% | 77 | 64 | 91.61 | +77.6% | 66 | 0.83 |
|
PETR3
|
50.29 | 648.2B | 5.94 | 1.46 | 3.91 | 12.7% | 11.2% | 73 | 62 | 90.87 | +60.5% | 66 | 0.83 |
|
RECV3
|
10.89 | 3.2B | 5.98 | 0.76 | 3.66 | 7.1% | 12.6% | 66 | 46 | 18.72 | +53.9% | 66 | 0.77 |
|
UGPA3
|
34.82 | 37.3B | 12.44 | 2.26 | 5.91 | 11.1% | 13.8% | 55 | 44 | 33.52 | -2.7% | 69 | 1.28 |
|
VBBR3
|
34.42 | 41.2B | 13.76 | 1.89 | 8.06 | 14.7% | 14.2% | 51 | 39 | 30.39 | -8.8% | 61 | 1.10 |
|
CSAN3
|
3.90 | 15.4B | — | 4.40 | 14.14 | 12.7% | 7.6% | 46 | 67 | 4.32 | +6.9% | 28 | 18.57 |
|
PRIO3
|
62.68 | 50.0B | 100.00 | 9.81 | 33.60 | 3.1% | 16.7% | 29 | 15 | 15.67 | -51.8% | 71 | 0.99 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.